{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T07:50:33Z","timestamp":1789977033217,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Primary Care: Clinics in Office Practice"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.pop.2009.01.004","type":"journal-article","created":{"date-parts":[[2009,6,5]],"date-time":"2009-06-05T05:21:14Z","timestamp":1244179274000},"page":"407-415","source":"Crossref","is-referenced-by-count":5,"title":["Pharmacotherapy for the Obese Patient"],"prefix":"10.1016","volume":"36","author":[{"given":"Lori M.","family":"Dickerson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Carek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pop.2009.01.004_bib1","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.295.13.1549","article-title":"Prevalence of overweight and obesity in the United States, 1999\u20132004","volume":"295","author":"Ogden","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.pop.2009.01.004_bib2","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1001\/jama.298.17.2028","article-title":"Cause-specific excess deaths associated with underweight, overweight, and obesity","volume":"298","author":"Flegal","year":"2007","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.pop.2009.01.004_bib3","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJMra012586","article-title":"Obesity","volume":"346","author":"Yanovski","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pop.2009.01.004_bib4","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1210\/er.20.6.805","article-title":"Current and potential drugs for treatment of obesity","volume":"20","author":"Bray","year":"1999","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pop.2009.01.004_bib5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1345\/aph.17039","article-title":"Update on the pharmacotherapy of obesity","volume":"32","author":"Cerulli","year":"1998","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.pop.2009.01.004_bib6","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2165\/00003495-199957060-00005","article-title":"Current concepts in the pharmacological treatment of obesity","volume":"57","author":"Carek","year":"1999","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.pop.2009.01.004_bib7","first-page":"2131","article-title":"Pharmacological treatment for obesity","volume":"61","author":"Dickerson","year":"2000","journal-title":"Am Fam Physician"},{"issue":"18","key":"10.1016\/j.pop.2009.01.004_bib8","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJMcp0801652","article-title":"Nonsurgical management of obesity in adults","volume":"358","author":"Eckel","year":"2008","journal-title":"N Engl J Med"},{"issue":"68","key":"10.1016\/j.pop.2009.01.004_bib9","first-page":"23","article-title":"Diet, drugs and surgery for weight loss","volume":"6","author":"Anon","year":"2008","journal-title":"Treat Guidel Med Lett"},{"key":"10.1016\/j.pop.2009.01.004_bib10","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1136\/bmj.39385.413113.25","article-title":"Long-term pharmacotherapy for obesity and overweight: Updated meta-analysis","volume":"335","author":"Rucker","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.pop.2009.01.004_bib11","series-title":"The practical guide: identification, evaluation, and treatment of overweight and obesity in adults","year":"2000"},{"key":"10.1016\/j.pop.2009.01.004_bib12","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1345\/aph.1G333","article-title":"Medications associated with weight gain","volume":"39","author":"Malone","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.pop.2009.01.004_bib13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.2007.56-b","article-title":"Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial","volume":"299","author":"Wu","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.pop.2009.01.004_bib14","doi-asserted-by":"crossref","first-page":"707","DOI":"10.7326\/0003-4819-119-7_Part_2-199310011-00016","article-title":"Use and abuse of appetite-suppressant drugs in the treatment of obesity","volume":"119","author":"Bray","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pop.2009.01.004_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2265.1991.tb03490.x","article-title":"The management of obesity","volume":"35","author":"Jung","year":"1991","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.pop.2009.01.004_bib16","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1056\/NEJM199508103330612","article-title":"The \u00df3-adrenergic receptor - a cause and cure for obesity","volume":"333","author":"Arner","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pop.2009.01.004_bib17","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1056\/NEJM200012213432501","article-title":"Phenylpropanolamine and the risk of hemorrhagic stroke","volume":"343","author":"Kernan","year":"2000","journal-title":"N Engl J Med"},{"issue":"Suppl 4","key":"10.1016\/j.pop.2009.01.004_bib18","doi-asserted-by":"crossref","first-page":"425s","DOI":"10.1002\/j.1550-8528.1995.tb00209.x","article-title":"Evaluation of drugs for treating obesity","volume":"3","author":"Bray","year":"1995","journal-title":"Obes Res"},{"key":"10.1016\/j.pop.2009.01.004_bib19","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/sj.ijo.0801889","article-title":"Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials","volume":"26","author":"Haddock","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.pop.2009.01.004_bib20","doi-asserted-by":"crossref","first-page":"532","DOI":"10.7326\/0003-4819-142-7-200504050-00012","article-title":"Meta-analysis: pharmacological treatment of obesity","volume":"142","author":"Li","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pop.2009.01.004_bib21","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/ajcn\/60.5.647","article-title":"Long-term weight loss: The effect of pharmacologic agents","volume":"60","author":"Goldstein","year":"1994","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.pop.2009.01.004_bib22","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/archinte.144.6.1143","article-title":"A double-blind clinical trial in weight control: Use of fenfluramine and phentermine alone and in combination","volume":"144","author":"Weintraub","year":"1984","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pop.2009.01.004_bib24","first-page":"91","article-title":"The acute effect of dexfluramine on resting metabolic rate and post prandial thermogenesis in obese subjects: a double blind placebo controlled study","volume":"17","author":"Scalfi","year":"1993","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.pop.2009.01.004_bib25","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1001\/jama.283.13.1738","article-title":"Heart valve disorders and appetite-suppressant drugs","volume":"283","author":"Jick","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.pop.2009.01.004_bib26","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1001\/jama.276.23.1907","article-title":"Long-term pharmacotherapy in the management of obesity","volume":"276","author":"National Task Force on the Prevention and Treatment of Obesity","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.pop.2009.01.004_bib27","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/j.1552-4604.1997.tb04323.x","article-title":"The pharmacologic approach to the treatment of obesity","volume":"37","author":"Weiser","year":"1997","journal-title":"J Clin Pharmacol"},{"issue":"Suppl 2","key":"10.1016\/j.pop.2009.01.004_bib28","first-page":"145","article-title":"Sibutramine: weight loss in depressed patients","volume":"19","author":"Kelly","year":"1995","journal-title":"Int J\u00a0Obes"},{"key":"10.1016\/j.pop.2009.01.004_bib29","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/S0140-6736(00)03491-7","article-title":"Effect of sibutramine on weight maintenance after weight loss: a randomised trial","volume":"356","author":"James","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.pop.2009.01.004_bib30","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/j.1550-8528.1999.tb00419.x","article-title":"Absence of cardiac valve dysfunction in obese patients treated with sibutramine","volume":"7","author":"Bach","year":"1999","journal-title":"Obes Res"},{"key":"10.1016\/j.pop.2009.01.004_bib31","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1067\/mhj.2002.124403","article-title":"Effects of sibutramine on ventricular dimensions and heart valves in obese patients during weight reduction","volume":"144","author":"Zannad","year":"2002","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.pop.2009.01.004_bib32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0025-7125(05)70599-X","article-title":"Obesity","volume":"82","author":"Aronne","year":"1998","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.pop.2009.01.004_bib33","first-page":"241","article-title":"Lipase inhibition: a novel concept in the treatment of obesity","volume":"17","author":"Drent","year":"1993","journal-title":"Int J Obes"},{"issue":"4","key":"10.1016\/j.pop.2009.01.004_bib34","first-page":"221","article-title":"Orlistat (Ro 18-0647), a lipase inhibitor, in the treatment of human obesity: multiple dose study","volume":"19","author":"Drent","year":"1995","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"Suppl 3","key":"10.1016\/j.pop.2009.01.004_bib35","first-page":"S24","article-title":"A one-year trial to assess the value of orlistat in the management of obesity","volume":"21","author":"James","year":"1997","journal-title":"Int J Obes"},{"issue":"10","key":"10.1016\/j.pop.2009.01.004_bib36","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.2165\/00003495-200565100-00006","article-title":"Pharmacotherapy for obesity","volume":"65","author":"Ioannides-Demos","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.pop.2009.01.004_bib37","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/oby.2002.86","article-title":"Buproprion SR enhances weight loss: a 48-week double-blind, placebo-controlled trial","volume":"10","author":"Anderson","year":"2002","journal-title":"Obes Res"},{"issue":"1","key":"10.1016\/j.pop.2009.01.004_bib38","article-title":"Zonisamide add-on for drug-resistant partial epilepsy","author":"Chadwick","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pop.2009.01.004_bib39","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.2337\/dc06-2001","article-title":"A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of topiramate controlled release in the treatment of obese type 2 diabetic patients","volume":"30","author":"Rosenstock","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pop.2009.01.004_bib40","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/S0140-6736(07)61721-8","article-title":"Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomized trials","volume":"370","author":"Christensen","year":"2007","journal-title":"Lancet"}],"container-title":["Primary Care: Clinics in Office Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454309000165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454309000165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T13:01:00Z","timestamp":1558357260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095454309000165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0095454309000165"],"URL":"https:\/\/doi.org\/10.1016\/j.pop.2009.01.004","relation":{},"ISSN":["0095-4543"],"issn-type":[{"value":"0095-4543","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}